438 related articles for article (PubMed ID: 27349294)
1. Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception.
Sanders JN; Howell L; Saltzman HM; Schwarz EB; Thompson IS; Turok DK
Am J Obstet Gynecol; 2016 Nov; 215(5):592.e1-592.e5. PubMed ID: 27349294
[TBL] [Abstract][Full Text] [Related]
2. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
Turok DK; Sanders JN; Thompson IS; Royer PA; Eggebroten J; Gawron LM
Contraception; 2016 Jun; 93(6):526-32. PubMed ID: 26944863
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception.
BakenRa A; Gero A; Sanders J; Simmons R; Fay K; Turok DK
Obstet Gynecol; 2021 Jul; 138(1):79-84. PubMed ID: 34259467
[TBL] [Abstract][Full Text] [Related]
5. Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations.
Fay KE; Clement AC; Gero A; Kaiser JE; Sanders JN; BakenRa AA; Turok DK
Contraception; 2021 Nov; 104(5):561-566. PubMed ID: 34166648
[TBL] [Abstract][Full Text] [Related]
6. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.
Glasier AF; Cameron ST; Fine PM; Logan SJ; Casale W; Van Horn J; Sogor L; Blithe DL; Scherrer B; Mathe H; Jaspart A; Ulmann A; Gainer E
Lancet; 2010 Feb; 375(9714):555-62. PubMed ID: 20116841
[TBL] [Abstract][Full Text] [Related]
7. Interventions for emergency contraception.
Shen J; Che Y; Showell E; Chen K; Cheng L
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD001324. PubMed ID: 28766313
[TBL] [Abstract][Full Text] [Related]
8. Interventions for emergency contraception.
Shen J; Che Y; Showell E; Chen K; Cheng L
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD001324. PubMed ID: 30661244
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of emergency contraception options over 1 year.
Bellows BK; Tak CR; Sanders JN; Turok DK; Schwarz EB
Am J Obstet Gynecol; 2018 May; 218(5):508.e1-508.e9. PubMed ID: 29409847
[TBL] [Abstract][Full Text] [Related]
10. Frequency of same-day contraceptive initiation, recent unprotected intercourse, and pregnancy risk: a prospective cohort study of multiple contraceptive methods.
Torres E; Carter G; Gero A; Simmons RG; Sanders JN; Turok DK
Am J Obstet Gynecol; 2024 Jun; 230(6):661.e1-661.e7. PubMed ID: 38367756
[TBL] [Abstract][Full Text] [Related]
11. Emergency contraception.
Dunn S; Guilbert É;
J Obstet Gynaecol Can; 2012 Sep; 34(9):870-878. PubMed ID: 22971457
[TBL] [Abstract][Full Text] [Related]
12. Copper intrauterine device placement 6-14 days after unprotected sex.
Thompson I; Sanders JN; Schwarz EB; Boraas C; Turok DK
Contraception; 2019 Sep; 100(3):219-221. PubMed ID: 31176689
[TBL] [Abstract][Full Text] [Related]
13. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
[TBL] [Abstract][Full Text] [Related]
14. Emergency contraception: Oral and intrauterine options.
Black KI; Hussainy SY
Aust Fam Physician; 2017 Oct; 46(10):722-726. PubMed ID: 29036770
[TBL] [Abstract][Full Text] [Related]
15. One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: a randomized controlled trial.
Kaiser JE; Turok DK; Gero A; Gawron LM; Simmons RG; Sanders JN
Am J Obstet Gynecol; 2023 Apr; 228(4):438.e1-438.e10. PubMed ID: 36427600
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of the Copper T380A IUD and oral levonorgestrel for emergency contraception.
Turok DK; Gurtcheff SE; Handley E; Simonsen SE; Sok C; Murphy P
Contraception; 2010 Dec; 82(6):520-5. PubMed ID: 21074014
[TBL] [Abstract][Full Text] [Related]
17. A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.
Festin MP; Bahamondes L; Nguyen TM; Habib N; Thamkhantho M; Singh K; Gosavi A; Bartfai G; Bito T; Bahamondes MV; Kapp N
Hum Reprod; 2016 Mar; 31(3):530-40. PubMed ID: 26830816
[TBL] [Abstract][Full Text] [Related]
18. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
Eggebroten JL; Sanders JN; Turok DK
Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
[TBL] [Abstract][Full Text] [Related]
19. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.
Sanders JN; Turok DK; Royer PA; Thompson IS; Gawron LM; Storck KE
Contraception; 2017 Aug; 96(2):99-105. PubMed ID: 28596121
[TBL] [Abstract][Full Text] [Related]
20. Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception.
Achilles SL; Chen BA; Lee JK; Gariepy AM; Creinin MD
Contraception; 2015 Dec; 92(6):572-4. PubMed ID: 26297203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
